AVM Advanced Magnetics

Advanced Magnetics, Inc. to Present at Needham & Company's Fourth Annual Biotechnology Conference CAMBRIDGE, Mass., May 23 /PRNewswire-FirstCall/ -- Advanced Magnetics, Inc. (AMEX:AVM) today announced that Jerome Goldstein, Chairman, President and CEO of Advanced Magnetics, will present at Needham & Company's Fourth Annual Biotechnology Conference. The presentation is scheduled for Wednesday, May 25, 2005 at 11:00 am at the New York Palace Hotel in New York City. Mr. Goldstein's presentation will be webcast live and can be accessed by logging on to the investor relations section of Advanced Magnetics' website at http://www.advancedmagnetics.com/ on the day of the event. A replay of the presentation will also be available on the company's website. The two-day conference will feature presentations by a number of publicly- traded companies and will focus on drug development in the areas of cancer and cardiovascular diseases. About Advanced Magnetics Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide nanoparticles used in pharmaceutical products. As a leader in our field, we are dedicated to the development and commercialization of our proprietary nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cardiovascular disease and cancer. For more information about us, please visit our website at http://www.advancedmagnetics.com/, the content of which is not part of this press release. Contact: Lisa Gordon Director of Investor Relations Advanced Magnetics, Inc. (617) 497-2070 DATASOURCE: Advanced Magnetics, Inc. CONTACT: Lisa Gordon, Director of Investor Relations of Advanced Magnetics, Inc., +1-617-497-2070 Web site: http://www.advancedmagnetics.com/

Copyright